What are the Canadian Urological Association (CUA) third- and fourth-line treatment recommendations for interstitial cystitis/bladder pain syndrome (IC/BPS)?

Updated: Dec 04, 2020
  • Author: Eric S Rovner, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

Overall, CUA guidelines concur with the AUA third- and fourth-line treatment recommendations. The guidelines do note that sacral neuromodulation (SNM) is not yet approved by Health Canada or the US Food and Drug Administration (FDA) for the treatment of IC/BPS, but is indicated for urgency frequency syndrome and urgency urinary incontinence. [4]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!